CINP Newsletter October 2016



Congratulations to Professors Yamawaki, Kasper, and Kwon on the success of the 2016 CINP World Congress in Seoul, Korea

As we have now issued the call for proposals for the 2018 World Congress in Vienna, we should take a moment to celebrate our wonderful World Congress held in Seoul, Korea. I congratulate CINP Past-President, Shigeto Yamawaki, International Scientific Program Committee (ISPC) Chair, Siegfried Kasper, and Local Organizing Committee Chair, Jun Soo Kwon, for the vision and commitment that made this meeting such a great success. This team did a remarkable job and they set a very high standard for excellence for CINP.  We will try to live up to this standard for the 2018 World Congress in Vienna. Fortunately, we can count on the contributions of each of these individuals to our upcoming World Congress in Vienna, as Professor Kasper is the CINP President-Elect and Chair of the Local Organizing Committee for Vienna and Professors Yamawaki and Kwon have agreed to serve on the ISPC.


The CINP Thematic Meeting on Treatment-Resistant Mood Disorders in Prague, Czech Republic, July 20-22, 2017

CINP is transforming itself from a community that gathers “every other year” to a College that meets every year.

As a step in this path, we have planned a Thematic Meeting on ‘Treatment-Resistant Depression‘ for 2017. The Co-Chairs for this international meeting are Professors Cyril Hoschl from the Czech Republic and Siegfried Kasper from Austria.  Professors Gerard Sanacora, USA and Elias Eriksson, Sweden are the Co-Chairs of the International Scientific Programme Committee (ISPC).  This topic was selected because translational neuroscience research in this area is exploding, with the emergence of the first productive GWAS studies, a flowering of neuroimaging research on depression, advances in neurostimulation treatment, and the emergence of ketamine and other novel putative pharmacotherapies. Further, these advances in the biology and treatment of depression are paralleled in exciting molecular and cellular neuroscience studies that are laying a new foundation for our understanding of how these novel treatments might work. This is an exciting time for depression research and we hope to capture this moment with the 2017 CINP Thematic Meeting in Prague!  Please look for the preliminary programme which will be announced in December 2016 via our website, I hope to see you all there.


Introducing the CINP ISPC Co-Chairs for the 2018 Meeting, Professors Sahakian, UK and Picciotto, USA

The theme for the 2018 meeting is, “Neuropsychopharmacology: Meeting Global Challenges with Global Innovation”. The theme builds on evidence that neuropsychiatric disorders constitute the greatest single challenge to global health. Breakthroughs in psychiatric neuroscience are taking place on every continent. Thus, it is fitting that the CINP, a global scientific and clinical community, returns to Vienna, the home of Sigmund Freud and the first psychiatry Nobel Prize, to take stock of this progress and to chart the future of our field.

I am thrilled to introduce the two exceptional translational neuroscientists who will lead the IPSC for the 2018 World Congress, Professors Barbara Sahakian and Marina Picciotto. These two scientists are leaders in the synergistic fields that are transforming psychiatry research,  clinical cognitive neuroscience and molecular and systems neuroscience, respectively. Unlike the CINP elected officials, the co-chairs of the ISPC may be new to some CINP members. Therefore, I will take this opportunity to introduce them briefly here.



Building New Bridges Between CINP, National Colleges of Neuropsychopharmacology, and Other Relevant Organizations

Consistent with the theme of the 2018 CINP World Congress in Vienna, the challenges of mental illness are global and the solutions will likely emerge from groups working around the world. CINP is one of very few organizations to espouse this global agenda. There is growing openness to advancing this global agenda among a number of leading organizations, such as the ACNP and Society of Biological Psychiatry (SOBP). The leadership of these organizations have been meeting to consider how we might work together more effectively.  These discussions resulted in efforts to increase the visibility of CINP and its mission within both ACNP and SOBP and an SOBP-sponsored symposium at the 2016 World Congress in Seoul.

A core value for CINP as it works toward its goal of building a global scientific community is to foster the vitality of the corresponding national, regional, and continental organizations, such as ECNP, AsCNP, KCNP, and JSNP. It is exciting that new Colleges continue to emerge, such as the African College of Neuropsychopharmacology, AfCNPF. CINP leadership would like to hear from the leadership of new and established Colleges to learn more about their priorities and objectives and to insure that they are represented on the CINP Corresponding Organizations Committee.

Most importantly, CINP Leadership would like to hear about ways that CINP could be of more value to the corresponding Colleges. CINP has provided support in a variety of ways, including hosting satellite meetings at World Congresses (such as the wonderful JSNP Satellite Meeting at the 2016 World Congress in Seoul), engagement of the Education Committee in meeting local training needs, and working with other Colleges on collaborative projects (such as Public-Private Partnerships, the Neuroscience-based Nomenclature, and other projects). I would like to hear from the leaders of established and emerging Colleges about these and other ways that CINP can assist you in achieving your aims or might work together to achieve common objectives.

Please feel free to contact me via our Central Office here.


Get the CINP app: